(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Four years ago when the first European Symposium on the re lationship between alterations of blood clotting mechanisms and atherosclerosis was organized, we asked ourselves which would be the best way to obtain both scientific and practical contributions. We have been interested in cardiovascular diseases for several years now and have therefore focused our attention on the "container" (Le. the blood vessel) rather than on the "contents" (Le. the various components of blood) as considered only from a haemodynamic point of view. In recent years correlations were found between alterations of vascular wall and alteration of coagulative, fibrinolytic, and plate let factors as well as of haemorheological phenomena in the thrombo genic evolution of atherosclerotic lesions. A close cooperation between cardiologists and workers interested in atherosclerosis and thrombosis is therefore necessary. We think that the most appropriate approach to the various problems concerning correlations between thrombogenic and atherosclerotic lesions is co-operation between experts in these different fields of research. We thus decided to organize the 2nd Symposium taking into account the great progress achieved in this field during the past few years, and hope that discussions on diagnostic and therapeutical perspec' tives will yield useful elements both for the cardiologist and for the cardiologist and for the general practitioner.
Contents:
Thrombosis in Coronary Heart Disease: An Assessment of the Present State.- Working Group of the European Society of Cardiology.- Haemostatic Function and Ischaemic Heart Disease.- Pathology of Arterial Thrombosis.- Clotting System in Prethrombotic State.- Platelet Function Tests and Coronary Heart Disease.- Impairment of Fibrinolysis and Vascular Disease.- Coagulation and Vascular Diseases.- Antithrombin III and Atherosclerosis.- Factor VIII and Antithrombin III in Atherosclerosis Obliterans of the Lower Limbs.- Advances in the Prevention of Venous Thromboembolic Disease.- Current Status of Anticoagulant Treatment.- Vascular Complications of Diabetes Mellitus.- Blood Viscosity and the Complications of Diabetes.- Factors Contributing to Platelet Hyperactivity in Diabetes Mellitus.- Platelet Activity and Blood Lipid Changes in Diabetes Mellitus.- Platelet Prostaglandins and Related Compounds in Diabetes Mellitus.- Platelet Function and Vascular Diseases.- Risk Factors for Coronary Heart Disease and Platelet Functions.- On the Mechanism of Platelet Activation During Hemostasis and Thrombosis and on the Effects of Platelet Inhibiting Drugs.- Methods for the Detection of Activated Platelets.- Platelet Function Changes in Acute Myocardial Infarction.- Role of Prostacyclin and Thromboxane A2 in Ischaemic Heart Disease.- Gyki 14,451, a Synthetic Tripeptide Inhibitor of Thrombin: "In Vitro" and "In Vivo" Studies.- Prostacyclin and its Analogues for the Therapy of Thromboembolic Disorders.- Prostacyclin in the Treatment of Atherosclerosis Obliterans and Other Vascular Diseases.- Fibrinolysis and Vascular Diseases.- Molecular Mechanism of Fibrinolysis.- The Biological Role of Fibrinolysis.- Fibrinolysis and Body Weight: Fibrinolytic Response to Venous Occlusion in Obese Children.- Fibrinolytic Vessel Wall Activator in Arterial Thrombosis.- Long-term Induction of Fibrinolytic Activity in Chronic Arterial Vessel Disease.- Hypertensive Vascular Disease.- Free (Unconjugated) Catecholamine Concentrations in Platelets: Biological Significance and Clinical Implications.- Prostaglandins and Hypertension.- Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs.- Haemodynamic and Antihypertensive Effect of Prostacyclin.- Pulmonary Vascular Diseases.- Mechanisms Underlying Pulmonary Hypertension by Hypoxemia.- Platelets, Hypoxemia and Pulmonary Hypertension.- The Diagnosis and Management of Pulmonary Embolism.- Platelet Activity in Relation to Smoke and Exercise in Patients with Chronic Obstructive Lung Disease: Effects of Platelet Antiaggregating Drugs.- Vasodilator Treatment of Primary Pulmonary Hypertension.- The Thrombogenic Risk in Chronic Respiratory Failure.- Conclusions.- Haemorheology and Vascular Disease.- Basic Rheology of Mammalian Blood: Factors Promoting and Factors Interfering with Fluidity of Blood.- The Red Cell as a Risk Factor in Circulatory Diseases.- Haemorheological Parameters in Some Vascular Diseases.- Evaluation of the Haemorheological Determinants in Coronary Heart Disease.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: December, 2012
Pages: None
Weight: 832g
Availability: Available
Subcategories: Cardiovascular Medicine
From the same series
